Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:28 PM
Ignite Modification Date:
2025-12-24 @ 1:28 PM
NCT ID:
NCT01440595
Eligibility Criteria:
Inclusion Criteria:
* Body weight ≥ 88 lbs and ≤ 275 lbs
* Documented chronic Hepatitis C (CHC) GT2 or GT3 infection
* No known cirrhosis
* Agrees to use two acceptable methods of birth control during study and through 6 months after last dose of study drug
* Chest X-ray within the last 6 months
* Eye exam within the last 6 months
Exclusion Criteria:
* Known to be human immunodeficiency virus (HIV) positive or co-infected with active hepatitis B virus (positive for Hepatitis B surface antigen)
* Prior approved or investigational treatment for hepatitis C
* Evidence of hepatocellular carcinoma
* Diabetic and/or high blood pressure with clinically significant eye exam findings
* Pre-existing psychiatric condition
* Clinical diagnosis of abuse of certain substances within specified timeframes
* Known medical condition that could interfere with participation
* Active or suspected cancer within the last 5 years
* Female who is pregnant, breastfeeding, or expecting to conceive or donate eggs
* Male who is planning to impregnate partner or donate sperm
* Male with a pregnant female partner
* Chronic hepatitis not caused by HCV
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01440595
Study Brief:
Protocol Section:
NCT01440595